Orthopediatrics Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Orthopediatrics Corp inventory turnover ratio, the Orthopediatrics Corp's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 0.5 in the third quarter 2026, KIDS's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Orthopediatrics in Sep 30 2026 quarter, has decreased to 730 days, compare to 745 days, in the Jun 30 2026 quarter.

Within Healthcare sector 353 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1880 in the second quarter 2026, to 1920.

KIDS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Orthopediatrics Corp Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

KIDS Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Inventory Growth	10.14 %	9.82 %	11.92 %	14.35 %	6.51 %
Y / Y Cost of Sales Growth	24.57 %	6.72 %	7.14 %	-5.56 %	7.14 %
Inventory Turnover Ratio (TTM)	0.5	0.49	0.49	0.5	0.52
KIDS's Total Ranking	# 1920	# 1880	# 1305	# 1197	#
Average inventory processing period	726	748	744	735	700
Seq. Inventory Growth	3.12 %	2.65 %	0.17 %	3.87 %	2.83 %
Seq. Cost of Sales Growth	2.99 %	20.95 %	-11.76 %	13.33 %	-11.76 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 156
Healthcare Sector	# 354
Overall Market	# 1920

Inventory Turnover Ratio Statistics
High	Average	Low
0.79	0.46	0.32
(Sep 30 2018)		(Dec 31 2020)

KIDS Company Profile >> Back to KIDS Efficiency Comparisons >> Compare KIDS Inventory Turnover Ratio to its Competitors

Financial Statements
Orthopediatrics's Inventories	$ 142 Millions	Visit KIDS's Balance sheet
Orthopediatrics's Cost of Revenues TTM	$ 69 Millions	Visit KIDS's Income Statement
What are KIDS's Sales?		Visit KIDS's Sales by Segment

Other Inventory Turnover Ratios
Orthopediatrics's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
KIDS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for KIDS's Competitors
Inventory Turnover Ratio for KIDS's Suppliers
Inventory Turnover Ratio for KIDS's Customers

You may also want to know
KIDS's Sales Growth Rates	KIDS's Pe Price to earnings ratio	KIDS's Receivables Turnover Ratio	KIDS's Stock Quote
KIDS's Net Income Growth Rates	KIDS's Ps Price to Sales ratio	KIDS's Sales per Employee	KIDS's Asset Turnover Ratio
KIDS's Net Margin	KIDS's Pb Price to Book ratio	KIDS's Financial Strength Ratios	KIDS's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Aurinia Pharmaceuticals Inc	1.29	$ 30.165 Millions	$ 23 Millions
Pulmonx Corporation	1.28	$ 20.450 Millions	$ 16 Millions
Alphatec Holdings Inc	1.27	$ 241.341 Millions	$ 189 Millions
Si bone inc	1.25	$ 46.999 Millions	$ 38 Millions
Bridgebio Pharma Inc	1.24	$ 53.542 Millions	$ 43 Millions
Biogen Inc	1.23	$ 2,681.800 Millions	$ 2,181 Millions
Kiniksa Pharmaceuticals International Plc	1.21	$ 93.072 Millions	$ 77 Millions
Mannkind Corporation	1.16	$ 51.332 Millions	$ 44 Millions
Rhythm Pharmaceuticals Inc	1.14	$ 33.056 Millions	$ 29 Millions
Penumbra Inc	1.13	$ 499.548 Millions	$ 443 Millions
Teleflex Incorporated	1.12	$ 427.166 Millions	$ 380 Millions
Acadia Pharmaceuticals Inc	1.12	$ 114.422 Millions	$ 102 Millions
Corcept Therapeutics Inc	1.11	$ 14.097 Millions	$ 13 Millions
Alkermes Plc	1.10	$ 300.119 Millions	$ 273 Millions
Neurocrine Biosciences Inc	1.07	$ 81.200 Millions	$ 76 Millions
Emergent Biosolutions Inc	1.07	$ 334.800 Millions	$ 314 Millions
Vertex Pharmaceuticals Inc	1.00	$ 1,874.100 Millions	$ 1,866 Millions
Amarin Corp Plcuk	0.92	$ 104.502 Millions	$ 113 Millions
Eli Lilly And Company	0.89	$ 14,149.700 Millions	$ 15,815 Millions
Cerus Corporation	0.87	$ 54.000 Millions	$ 62 Millions
Rxsight Inc	0.82	$ 29.342 Millions	$ 36 Millions
Profound Medical Corp	0.79	$ 6.177 Millions	$ 8 Millions
Inspire Medical Systems inc	0.74	$ 122.959 Millions	$ 165 Millions
Butterfly Network Inc	0.62	$ 37.120 Millions	$ 60 Millions
Regeneron Pharmaceuticals Inc	0.60	$ 1,842.200 Millions	$ 3,071 Millions
Lenz Therapeutics Inc	0.58	$ 2.228 Millions	$ 4 Millions
Lexicon Pharmaceuticals Inc	0.58	$ 0.427 Millions	$ 1 Millions
Biomarin Pharmaceutical Inc	0.57	$ 878.919 Millions	$ 1,538 Millions
Verastem Inc	0.51	$ 1.117 Millions	$ 2 Millions
Orthopediatrics Corp	0.50	$ 68.827 Millions	$ 137 Millions

Date modified: 2026-10-29T10:03:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.